Chen Huale, Hu Panjie, Wang Yaran, Liu Haifeng, Zheng Junyuan, Huang Zeyu, Zhang Xiaotuan, Liu Yong, Zhou Tieli
Department of Clinical Laboratory, The First Affiliated Hospital of Wenzhou Medical University; Key Laboratory of Clinical Laboratory Diagnosis and Translational Research of Zhejiang Province, Wenzhou, Zhejiang, China; Department of Clinical Laboratory, The Second Affiliated Hospital and Yuying Children's Hospital of Wenzhou Medical University, Wenzhou, Zhejiang, China.
Department of Clinical Laboratory, The First Affiliated Hospital of Wenzhou Medical University; Key Laboratory of Clinical Laboratory Diagnosis and Translational Research of Zhejiang Province, Wenzhou, Zhejiang, China.
Colloids Surf B Biointerfaces. 2025 Mar;247:114415. doi: 10.1016/j.colsurfb.2024.114415. Epub 2024 Nov 28.
To address the pressing challenge of antibiotic resistance, particularly the robust defense mechanisms of Pseudomonas aeruginosa (P. aeruginosa) against conventional antibiotics, this study employs nanotechnology to enhance antimicrobial efficacy while ensuring good biocompatibility with the host. In this study, gold nanoparticles were chemically decorated with eugenol, a phenol-rich natural compound, using a one-pot synthesis method. The successful synthesis and functionalization of eugenol-decorated gold nanoparticles (Eugenol_Au NPs) were validated by comprehensive physicochemical analyses, demonstrating their stability and biocompatibility. These nanoparticles exhibited potent antimicrobial activity against both planktonic and biofilm-embedded carbapenem-resistant P. aeruginosa strains. Eugenol_Au NPs disrupted the bacterial quorum sensing system and stimulated intracellular reactive oxygen species production, which enhance their antibacterial effects. This dual mechanism of action has promising clinical implications for the treatment of infections associated with antibiotic-resistant P. aeruginosa. In vivo assessments in a murine peritoneal infection model showed that Eugenol_Au NPs significantly reduced bacterial loads and mitigated inflammatory responses, thereby improving survival rates. The study highlights the potential of Eugenol_Au NPs as an alternative strategy for refractory infections caused by carbapenem-resistant P. aeruginosa, and underscores the feasibility and promise of further clinical research and development of new therapeutic approaches targeting this resistant pathogen.
为应对抗生素耐药性这一紧迫挑战,尤其是铜绿假单胞菌(P. aeruginosa)对传统抗生素的强大防御机制,本研究采用纳米技术提高抗菌效果,同时确保与宿主具有良好的生物相容性。在本研究中,使用一锅合成法将富含酚类的天然化合物丁香酚化学修饰在金纳米颗粒上。通过全面的物理化学分析验证了丁香酚修饰的金纳米颗粒(Eugenol_Au NPs)的成功合成和功能化,证明了它们的稳定性和生物相容性。这些纳米颗粒对浮游和生物膜包裹的耐碳青霉烯铜绿假单胞菌菌株均表现出强大的抗菌活性。Eugenol_Au NPs破坏了细菌群体感应系统并刺激细胞内活性氧的产生,从而增强了它们的抗菌效果。这种双重作用机制对于治疗与耐抗生素铜绿假单胞菌相关的感染具有广阔的临床应用前景。在小鼠腹腔感染模型中的体内评估表明,Eugenol_Au NPs显著降低了细菌载量并减轻了炎症反应,从而提高了存活率。该研究突出了Eugenol_Au NPs作为耐碳青霉烯铜绿假单胞菌引起的难治性感染替代策略的潜力,并强调了针对这种耐药病原体的新治疗方法进一步开展临床研究和开发的可行性和前景。